{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:55:32Z","timestamp":1790794532895,"version":"4.1.0"},"reference-count":7,"publisher":"American Society for Clinical Investigation","issue":"19","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"DOI":"10.1172\/jci211778","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:01:22Z","timestamp":1790791282000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessing clinical relevance of off-target effects observed at suprapharmacological concentrations of SGLT2 inhibitors. Reply."],"prefix":"10.1172","volume":"136","author":[{"given":"Abdualrahman Mohammed","family":"Abdualkader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Al Batran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI210991"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI192333"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0910040106"},{"key":"B4","unstructured":"Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (empagliflozin) prescribing information. https:\/\/pro.boehringer-ingelheim.com\/us\/products\/jardiance\/bipdf\/jardiance-us-prescribing-information Updated January 2026. Accessed August 18, 2026"},{"key":"B5","unstructured":"US Food and Drug Administration. Pharmacology\/Toxicology Review and Evaluation: Empagliflozin (JARDIANCE), NDA 204629Orig1s000. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/204629Orig1s000AdminCorres.pdf Accessed August 18, 2026"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061210"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.124.324823"}],"container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jci.org\/articles\/view\/211778\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:02:17Z","timestamp":1790791337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jci.org\/articles\/view\/211778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":7,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,8,11]]},"published-print":{"date-parts":[[2026,10,1]]}},"alternative-id":["10.1172\/JCI211778"],"URL":"https:\/\/doi.org\/10.1172\/jci211778","relation":{},"ISSN":["1558-8238"],"issn-type":[{"value":"1558-8238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"e211778"}}